PetMed Express Q4 Revenue Drops 15.6% to $42.82M, EPS Loss Narrows
PETS•PetMed Express reported a fourth-quarter loss per share of $0.19, improved from a $0.56 loss a year earlier, missing estimates by $0.01. Quarterly revenue fell 15.6% to $42.82 million, while its price-to-earnings ratio remained negative at -0.78 and price-to-sales ratio was 0.25.
1. Q4 Earnings Performance
PetMed Express reported a fourth-quarter loss per share of $0.19, missing the consensus by $0.01 but improving from a $0.56 loss in the prior-year period. Revenue declined 15.6% year over year to $42.82 million, primarily due to reduced prescription medication sales.
2. Valuation Ratios
The company's price-to-earnings ratio remains negative at -0.78, reflecting continued unprofitability over the last year, while its price-to-sales ratio stands at 0.25, highlighting modest valuation relative to revenue.
3. Balance Sheet Analysis
PetMed Express carries minimal leverage with a debt-to-equity ratio of 0.02, but its current ratio of 0.84 below 1.0 suggests short-term liabilities exceed liquid assets.
